Kerry L Kilbridge
Overview
Explore the profile of Kerry L Kilbridge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravi P, Zhong C, Xie W, Kelly E, Whelpley B, Kuczmarski K, et al.
Eur Urol Oncol
. 2024 Nov;
PMID: 39547900
Background And Objective: It is unclear whether "total therapy" (androgen deprivation therapy [ADT] with or without an androgen receptor pathway inhibitor [ARPI], metastasis-directed therapy, and local therapy to the prostate...
2.
Kilbridge K, Patil D, Filson C, Shelton J, Thomson S, Rosenbaum C, et al.
Cancer
. 2024 Sep;
130 Suppl 20:3602-3611.
PMID: 39254372
Background: Poor comprehension of prostate cancer (PCa) medical terms can create barriers to PCa treatment discussions. The authors measured comprehension of PCa terms and its relationship to health literacy in...
3.
Ravi P, Whelpley B, Kelly E, Wolanski A, Ritzer J, Robertson M, et al.
J Nucl Med
. 2023 Jan;
64(3):349-350.
PMID: 36702553
No abstract available.
4.
Wrenn S, Moore A, Shah H, Barletta J, Vaidya A, Kilbridge K, et al.
Am J Surg
. 2022 Sep;
225(2):309-314.
PMID: 36137821
Background: Adrenocortical carcinoma (ACC) is an aggressive, rare malignancy. 2-deoxy-2-[18F]-fluoro-d-glucose positron emission tomography (FDG-PET) assesses tumor metabolism and glucose utilization. We hypothesized that higher maximum standard uptake value (SUV) is...
5.
Sonpavde G, Maughan B, McGregor B, Wei X, Kilbridge K, Lee R, et al.
Cancer Immunol Immunother
. 2022 Aug;
72(3):775-782.
PMID: 35998004
CV301 comprises recombinant poxviruses, Modified Vaccinia Ankara (MVA) and Fowlpox (FPV), encoding CEA, MUC-1, and co-stimulatory Molecules (TRICOM) ICAM-1, LFA-3, and B7-1. MVA-BN-CV301 is used for priming and FPV-CV301 is...
6.
Ravi P, Ravi A, Riaz I, Freeman D, Curran C, Mantia C, et al.
Oncologist
. 2022 Mar;
27(5):e406-e409.
PMID: 35294031
Serial evaluation of circulating tumor DNA may allow noninvasive assessment of drivers of resistance to immune checkpoint inhibitors (ICIs) in advanced urothelial cancer (aUC). We used a novel, amplicon-based next-generation...
7.
McGregor B, Xie W, Adib E, Stadler W, Zakharia Y, Alva A, et al.
JCO Precis Oncol
. 2022 Feb;
6:e2100448.
PMID: 35171658
Purpose: Sapanisertib is a kinase inhibitor that inhibits both mammalian target of rapamycin complex 1 (mTORC1) and mTORC2. In this multicenter, single-arm phase II trial, we evaluated the efficacy of...
8.
Cone E, Reese S, Marchese M, Nabi J, McKay R, Kilbridge K, et al.
EClinicalMedicine
. 2021 Jul;
36:100887.
PMID: 34308305
Background: Androgen deprivation therapy (ADT) is standard-of-care for advanced prostate cancer. Studies have generally found increased cardiovascular risks associated with ADT, but the comparative risk of newer agents is under-characterized....
9.
Tully K, Cone E, Cole A, Sun M, Chen X, Marchese M, et al.
Am J Clin Oncol
. 2021 Jun;
44(8):413-418.
PMID: 34081033
Objective: The objective of this study was to examine the risk of immune-related adverse events (irAEs) in patients with a preexisting autoimmune disease (pAID) presenting with a cutaneous melanoma receiving...
10.
Rutan M, Sammon J, Nguyen D, Kilbridge K, Herzog P, Trinh Q
Am J Prev Med
. 2020 Dec;
60(2):e69-e72.
PMID: 33342672
Introduction: Health literacy affects how patients behave within the healthcare system. Overutilization of screening procedures inconsistent with the U.S. Preventive Services Task Force guidelines contributes to the high cost of...